![]() |
|
|
3 Children's Hospital, Oakland Research Institute, Oakland, CA 94690; 4 Jean Mayer USDA Human Nutrition Research Center on Aging, Boston, MA 02111; 5 Beltsville Human Nutrition Research Center, Beltsville, MD 20705; and 6 International Agency for Research on Cancer, WHO, 69008 Lyon, France
* To whom correspondence should be addressed. E-mail: jking{at}chori.org.
| ABSTRACT |
|---|
|
|
|---|
60% of the nuts consumed in the U.S. are eaten as snacks, emphasizing their use as a healthy snack may be more effective than inclusion within a food group.
Today, nuts and seeds continue to be enjoyed world-wide in a variety of ways, as recipe ingredients, spreads, snacks, and as a delicacy. In 2003, a qualified health claim (QHC)7 was approved by the FDA for nuts and cardiovascular disease, which read, "Scientific evidence suggests but does not prove that eating 1.5 ounces (42 g) per day of most nuts, as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease." Consuming 1.5 oz (42 g) of nuts per day would contribute
250 kcal/d (1.05 MJ/d). There is little information about whether this recommended intake is feasible and consistent with nut intakes reported by various population groups. The aim of this review, therefore, is to evaluate patterns of nut consumption in different populations, assess their impact on nutrient and phytochemical intakes, and determine how individuals frequently position nuts in the overall diet.
Total nut consumption
As interest in the health effects of nuts and seed consumption grows, so does the need to examine reliable data on nut consumption. In the past, most of the consumption information was based on food disappearance or market data for various regions or populations. Although consumption of specific types of nuts by individuals is available from dietary intake surveys, evaluating total nut intake is complicated by the fact that nuts are consumed not only in their whole form and as spreads but also as components of dishes and commercial products (breads, cereals, sweets, candy, etc.). The European Prospective Investigation into Cancer and Nutrition (EPIC) study, a large, multi-center prospective cohort in 10 Western European countries, assessed nut (tree nuts and peanuts) and seed intake from various dietary sources using detailed 24-h recalls in a 37,000-subject subset of the EPIC population (2). The 24-h recalls were collected using a computerized program (EPIC-Soft), which was standardized across the 10 European countries participating in EPIC.
The EPIC study determined the population mean intake and mean portion sizes in individuals reporting nut and seed consumption from all sources on the day that the 24-h recall was administered (2). The intake of nuts and seeds is reported as that consumed as whole, from hidden sources, or from spreads. The intake of total nuts (tree nuts, peanuts, and unspecified nuts) consumed whole was 2.23 g/d for the entire population (i.e. consumers and nonconsumers combined). The mean intake of total nuts varied
8-fold from northern to southern Europe, ranging from 0.61 g/d in Sweden to 4.83 g/d in Spain. The relatively low mean intakes reflect the fact that only
7% of the population surveyed consumed any type of nut (tree nuts, peanuts, or unspecified nuts) on the day that the 24-h recall was administered. Among tree nut consumers, the mean portion size of total tree nuts varied from 20.3 g/d in northern Europe (Denmark, Norway, and Sweden) to 29.1 g/d in Southern Europe (southern France, Greece, Italy, and Spain). This significant low-to-high gradient of intake was strengthened by the proportion of the population consuming tree nuts, which increased from 2.0% in the north to 6.3% in the south. The consumption of total tree nuts was highest in Spain where 8.3% of the population consumed
34.7 g on the day that the 24-h recall was administered. The mean intake of peanuts in the entire population was significantly higher in central European regions (northern France, Germany, Netherlands, UK; 1.5 g/d) than in either the North (0.7 g/d) or the South (0.8 g/d). A similar trend was apparent for the portion size of peanuts among consumers on the day of the 24-h recall (44.9 g/d in the central regions compared with 39.6 in the north and 37.6 in the south). For both total tree nuts and peanuts, differences by gender were also apparent from the EPIC data. Men reported a significantly larger portion size of total tree nuts (28.5 g/d) than women (23.1 g/d), although a higher percentage of women (4.8%) indicated consumption of total tree nuts than men (3.7%) on the day of the 24-h recall. Similarly, the portion size of peanuts was significantly higher in men (46.5 g/d) than in women (35.1 g/d), although the percentage of peanut consumers was relatively equal by gender. From the EPIC data, almost 50% of total nut consumption was from tree nuts, with walnuts, almonds, pistachios, and hazelnuts making up 86% of all tree nut consumption. Peanut consumption accounted for
37% of total nut consumption and the intake of unspecified nuts and seeds accounted for the rest. In the entire EPIC population surveyed by 24-h recalls,
4% consumed tree nuts, 2.3% consumed peanuts, and 1.3% reported consumption of seeds. The intake of tree nuts, peanuts, and seeds from hidden sources was higher in terms of percentage of consumers but lower in terms of portion size. Most of the intake of spreads was from peanuts, although the portion size of peanut spread (25.1 g/d) was lower than that of whole peanuts (39.6 g/d) among consumers. In the Netherlands, Norway, and Sweden, peanuts were more popular than tree nuts.
This comprehensive study of nut and seed consumption in 10 European countries shows that intake varies widely with geographical region and, presumably, cultural and gender influences on food patterns. Intakes were the highest in Mediterranean countries, where
8% of the surveyed population consumed
33.8 g/d, or
1.25 oz/d, of total nuts.
In the United States, nut consumption data has been derived from the 2001–2004 What We Eat in America (WWEIA)/NHANES (unpublished data), where nuts were given increased emphasis. During a 24-h dietary recall, an automated multiple pass method was used to obtain a more complete and accurate estimate of food consumption. After the individual listed all of the food and beverages consumed, the operator probed for forgotten food items. Nuts were on the list of potentially forgotten foods and individuals were asked specifically if nuts in any form or type were consumed in the previous 24-h period. In the WWEIA/NHANES 2001–2004 survey of 17,306 individuals, aged
2 y, 34% of those surveyed reported consuming nuts either as snacks, peanut butter, or as recipe ingredients. Six percent reported eating nuts as snacks, 8% as peanut butter, and 25% as foods that contained nuts as ingredients. Nut consumption among all individuals surveyed was 7.3 ± 0.36 (SEM) g/d. Among nut users, it was 21.4 ± 0.83 g/d. If nuts were consumed as snacks or as whole nuts, the mean consumption was 53.0 ± 2.17 g/d and was slightly higher for men (57 g/d) than for women (51 g/d). Mean intake of specific types of nuts eaten as snacks was led by peanuts at 25.8 g/d, followed by mixed nuts (that contained some peanuts) (10.4 g/d), cashews (6.3 g/d), almonds (4.1 g/d), pistachios (3.5 g/d), pecans (1.3 g/d), and walnuts (1.1 g/d). Tree nuts totaled 27 g/d. Of the foods that contributed nuts as ingredients in recipes or foods, candy was the top contributor at 46%, followed by baked items/desserts (24%), cookies (17%), ready-to-eat cereal (9%), and entrees (4%).
Thus, a higher percent of Americans (34%) report nut consumption than do Europeans (
7%) (tree nuts, peanuts, and unspecified nuts). However, the mean amount of nuts consumed by nut consumers in Europe (30.8 g/d) is higher than that in the US (21 g/d). This is only
50–60% of the 1.5 oz (42 g) recommended in the QHC.
Contribution of nutrients and other food components from nuts and seeds
The nutrient composition of tree nuts (almonds, Brazil nuts, cashews, hazel nuts, macadamias, pecans, pine nuts, pistachios, and walnuts) and peanuts is summarized in Table 1. One and one-half ounces of tree nuts or peanuts provides >10% of the adult male recommended dietary allowance (RDA) (31–50 y of age) for protein, iron, magnesium, phosphorus, zinc, copper, thiamin, and vitamin E. In addition, 1.5 oz (42 g) of tree nuts provides >10% of the adult male RDA for vitamin B-6 and selenium and this amount of peanuts provides >10% of the adult male RDA for niacin, pantothenic acid, and total folate. In WWEIA/NHANES 2001–2004, nuts made an important contribution to the total nutrient intakes of Americans who include nuts as snacks in their diets. Among individuals consuming nuts as snacks, nuts contributed between 25 and 35% of the following nutrients and diet components: fat, polyunsaturated fat, monounsaturated fat, linoleic acid, magnesium, copper, and vitamin E (unpublished data). However, among adults
19 y, the mean energy intake was significantly greater for both nut users and nut snackers than for nonusers. In comparison to male nonusers who consumed
2529 kcal/d (10.63 MJ/d), nut users consumed an additional 248 kcal/d (1.04 MJ/d) (P < 0.001) and the nut snackers consumed an additional 345 kcal/d (1.45 MJ/d) (P < 0.01). Among females, nut users consumed an additional 225 kcal/d (0.95 MJ/d) and nut snackers consumed an additional 271 kcal/d (1.14 MJ/d) compared with nonusers reporting total energy intakes of 1769 kcal/d (7.43 MJ/d). To adjust for the differences in mean daily energy intakes by nut use, mean intakes of nut eaters were compared with nonusers on a per-1000 kcal (4.20 MJ) basis (Table 2). Nutrients that were consumed in significantly higher amounts included vitamins E and K, food folate, β-carotene, lutein+zeaxanthin, magnesium, phosphorus, copper, selenium, potassium, and zinc, and those that were significantly lower included vitamin B-12, retinol, lycopene, and sodium. Body weight status by nut use and gender for adults showed did not differ in those classified as overweight even though they reported eating up to 250 additional kcal/d (1.05 MJ/d) with nuts in the diet (unpublished data). On the contrary, obese women (BMI
30) were less likely to consume nuts than nonconsumers (30 vs. 36%).
|
|
-tocopherol per serving among food groups in the U.S. food supply, nuts and seeds ranked only 7th as intake sources for men and 12th for women, due to their infrequent use (3).
The majority of the U.S. population also falls short of the recommended intake for magnesium. This mineral is required by numerous enzymes involved in nucleic acid metabolism and thereby affects multiple physiologic processes (5). Chronically low intakes are associated with risk of osteoporosis, hypertension, diabetes, and heart disease (6,7). It is thus important to note that population studies show mean and median intakes that fall well below current recommendations. For example, recent NHANES data showed that men consumed
350 mg/d and women consumed 250 mg/d, relative to RDA of 420 and 320 mg/d for men and women, respectively (8). Although magnesium is found in most whole foods, much is lost with processing. Inclusion of nuts and seeds can make a large contribution toward protection against the chronic insufficiency of magnesium intake that is widespread in the U.S. population. All nuts and seeds contain magnesium, but Brazil nuts, pumpkin seed kernels, almonds and cashews are particularly rich sources.
In addition to being a rich source of several essential vitamins and minerals, monounsaturated fatty acids and PUFA, and fiber, most tree nuts and peanuts provide an array of phytochemicals that may promote health and reduce the risk of chronic disease (9). Although many of these bioactive components of plant food remain to be fully identified and characterized, broad classes include the carotenoids, phenolic acids, phytosterols, and polyphenolic compounds such as flavonoids and stilbenes (10).
Phytosterols lower serum LDL cholesterol by inhibiting dietary cholesterol absorption, with an effective dose
2 g/d (11). The phytosterol content ranges from 95 mg/100 g in Brazil nuts to 280 mg/100 g in pistachios. This amount is comparable to concentrations found in chocolate and flax seed (12), though it is much lower than the amount formulated into some manufactured "functional food" products.
Carotenoids, specifically
- and β-carotene, β-cryptoxanthin, lutein, and zeaxanthin, are found in low concentrations (µg/100 g) in most nuts but at 1–3 mg/100 g in pistachios. No carotenoids have been reported in Brazil nuts, macadamias, or peanuts.
Plant phenols, including phenolic acids, flavonoids, and stilbenes, are also present in nuts. Walnuts are particularly rich in total phenols, with 1625 mg gallic acid equivalents/100 g (13). The stilbene resveratrol is found in peanuts and pistachios at 84 and 115 µg/100 g, respectively, in contrast to the 98–1803 µg/100 mL in red wine (14,15). Though complete information remains to be collected, the flavonoid content of nuts, as provided in the 2006 USDA Database for the Flavonoid Content of Selected Foods, includes the following totals for nuts: pecans, 34; almonds, 15; and pistachios and hazelnuts, 12 mg/100 g. No flavonoids have been detected in Brazil or macadamia nuts. Proanthocyanidins, oligomers of catechins, are found in almonds, cashews, hazelnuts, pecans, pistachios, peanuts, and walnuts, with concentrations varying from 9 to 494 mg/100 g in cashews and pecans, respectively (16). While most nuts contain small amounts of the antioxidant nutrients vitamin C and selenium, they are especially rich in vitamin E. The total phenolic constituents in nuts appear to contribute substantially to their total antioxidant capacity which, using the oxygen radical absorbance capacity assay, range from 204 (pine nuts) to 5095 (pecans) µmol Trolox equivalents/serving (7–179 µmol Trolox equivalents/g) comparable or greater to that found in a serving of beans (147–301), broccoli (700), carrots (741), and tomato (415) (17). Importantly, the phenols in almonds have been found to be bioavailable and act as antioxidants in vivo (18).
In sum, nut phytochemicals have been associated with an array of bioactivities, including antioxidant, antiviral, antiproliferative, hypocholesterolemic, and antiinflammatory actions potentially capable of affecting the initiation and progression of several pathogenic processes. For example, both observational evidence on nut intake (19) and clinical data from almond and walnut interventions (20,21) indicate their beneficial impact on inflammation [see article by Jenkins et al. in this symposium (22)].
Position of nuts in food or diet patterns
Nuts contain important nutrients that are consumed inadequately in the diet. The current dietary guidelines mention the nutritional value of nuts but do not specify nuts as a specific food group. Instead, nuts and seeds are part of the meat and beans group in the 2005 MyPyramid. One-half ounce (14 g) of nuts or seeds or 1 tablespoon (15 g) of peanut butter is considered to be nutritionally equivalent to 1 oz (28 g) of lean meat, poultry, or fish. A 2000-kcal (8.40 MJ) diet plan with 5.5-oz equivalents (154 g) from the meat and beans group could contain, therefore, 3 oz (84 g) meat and 2.5 tbsp (37.5 g) peanut butter or 1.25 oz (35 g) nuts or seeds. A 2800-kcal (11.76 MJ) diet plan with 7-oz equivalents (196 g) of meat and beans could contain 4 oz (112 g) meat and 3 tbsp (45 g) peanut butter or 1.5 oz (42 g) nuts or seeds, the amount included in the QHC.
However, it is difficult to place nuts in a typical U.S. diet as a meat replacement, because the amount of meat recommended is already low compared with the usual intake for some groups. For example, whereas Pyramid recommendations range from 5- to 7-oz equivalents/d (140–196 g/d) for adults, depending on calorie requirement level, men aged 30–39 y consume 7.9-oz equivalents (221 g)/d. Based on such comparisons, the USDA currently estimates that adult men need to decrease current meat group intakes by 20% to meet recommendations. Women tend to have mean meat group intakes closer to current recommendations, but a considerable proportion of women also exceed these recommendations. Because nuts are rich sources of fat and oils, many Americans think of them as alternatives to fat and oils instead of meat and bean substitutes. Alternatively, nuts could also be positioned in a plant protein group along with legumes. This would require changing the basic food group components in MyPyramid, however. Because
60% of the nuts consumed in the US are consumed as snacks, emphasizing the use of nuts as a healthy, tasty snack may be more effective than positioning them within a food group. For example, replacing snacks high in refined carbohydrates with nuts could have a positive impact on nutrient density and risk of chronic disease.
Ways to increase nut consumption have been proposed by MyPyramid and the Mediterranean diet educational tools. One approach involves using nuts as a condiment for various foods. Some examples are: add slivered almonds to steamed vegetables, add toasted nuts to vegetable stir-frys, sprinkle nuts on top of low-fat ice cream or frozen yogurt, add nuts to green salads instead of cheese or meats, and use ground nuts in sauces or as part of the flour in cakes and cookies.
Research needs
National 24-h dietary recalls in the US and Europe show that about one-fourth to one-third of the populations surveyed eat nuts on any single day. Actual intakes may be higher, because nuts are often eaten as snacks or added to mixed dishes in the diet, which individuals often fail to remember. To better evaluate the total intake of nuts, dietary assessment tools need to be developed that specifically address when and how nuts are consumed, the types and amounts of various nuts eaten, and how individuals primarily use nuts in their diets (as a snack or in recipes). To better evaluate the dietary role of nuts in the diet, research should be done on the placement of nuts in the diet. Nuts could be positioned in the diet in 4 ways: 1) as a substitute for meat; 2) as a plant protein source with legumes; 3) as a source of fat and oil; or 4) as a separate category of nuts and seeds. An assessment of how individuals think about nuts as a component of their diet will assist in making appropriate, population-based dietary guidance recommendations. This information is critical to increase per capita nut consumption from
3 to 7 g/d to the QHC recommendation of 42 g/d. Data on trends in nut consumption should be examined and tracked. If nut consumption is related to chronic disease, good data on long-term nut use is needed. A better understanding of the bioavailability of nutrients from nuts is also needed. A good biomarker of nut consumption would be helpful for tracking intake and health risks. Some possibilities might include serum or erythrocyte membrane fatty acid profiles.
The QHC recommends an intake of 1.5 oz nuts/d (42 g/d). The 2001–2004 NHANES data show that 6% of the individuals surveyed reported eating nuts "out-of-hand" and consumed a mean of 53 g nuts/d. These individuals met the QHC standard. Yet, there was no evidence that weight status changed significantly with nut use [see Mattes et al. in this issue (23)]. Data on what foods nuts replace in the diet, and how the dietary pattern changes with increased nut consumption, are needed. It is interesting that compared with nonusers of nuts, more Americans consuming nuts out-of-hand met the MyPyramid serving recommendations for meat/meat alternates (79 vs. 45%; P < 0.001) and oil (53 vs. 16%; P < 0.001) while staying within their discretionary energy allotment (8 vs. 5%; P < 0.05). This implies that the nuts consumed replaced other sources of energy in the diet.
Despite the promising results suggesting a link between nut phytochemicals and health outcomes, complete profiles of these ingredients are lacking for most nuts and relatively little direct information from studies on nuts is available on the bioavailability, distribution, metabolism, and elimination of these compounds. Similarly, new data are required to describe the impact on nut phytochemicals of cultivation, varieties, storage, and processing, including thermal treatments (15,24).
Other articles in this supplement include references (25–28).
| FOOTNOTES |
|---|
2 Author disclosures: The International Tree Nut Council Nutrition Research & Education Foundation and the Peanut Institute provided J. C. King, the primary author, with an honorarium and all authors with travel expenses. ![]()
7 Abbreviations used: EPIC, European Prospective Investigation into Cancer and Nutrition; QHC, qualified health claim; RDA, recommended dietary allowance; WWEIA, What We Eat in America. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Rainey C, Nyquist L. Nuts: nutrition and health benefits of daily use. Nutr Today. 1997;32:157–63.
2. Jenab M, Sabate J, Slimani N, Ferrari P, Mazuir M, Casagrande C, Deharveng G, Tjonneland A, Olsen A, et al. Consumption and portion sizes of tree nuts, peanuts and seeds in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts from 10 European countries. Br J Nutr. 2006;96 Suppl 2:S12–23.
3. Maras JE, Bermudez OI, Qiao N, Bakun PJ, Boody-Alter EL, Tucker KL. Intake of alpha-tocopherol is limited among US adults. J Am Diet Assoc. 2004;104:567–75.[CrossRef][Medline]
4. Gao X, Wilde PE, Lichtenstein AH, Bermudez OI, Tucker KL. The maximal amount of dietary alpha-tocopherol intake in U.S. adults (NHANES 2001–2002). J Nutr. 2006;136:1021–6.
5. Rude RK. Magnesium deficiency: a cause of heterogeneous disease in humans. J Bone Miner Res. 1998;13:749–58.[CrossRef][Medline]
6. Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr. 1999;69:727–36.
7. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol. 1995;48:927–40.[CrossRef][Medline]
8. Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of US adults. J Nutr. 2003;133:2879–82.
9. Dreher ML, Maher CV, Kearney P. The traditional and emerging role of nuts in healthful diets. Nutr Rev. 1996;54:241–5.[Medline]
10. Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr. 2004;134:S3479–85.
11. Muti P, Awad AB, Schunemann H, Fink CS, Hovey K, Freudenheim JL, Wu YW, Bellati C, Pala V, et al. A plant food-based diet modifies the serum beta-sitosterol concentration in hyperandrogenic postmenopausal women. J Nutr. 2003;133:4252–5.
12. Phillips KM, Ruggio DM, Ashraf-Khorassani M. Phytosterol composition of nuts and seeds commonly consumed in the United States. J Agric Food Chem. 2005;53:9436–45.[Medline]
13. Kornsteiner M, Wagner K-H, Elmadfa I. Tocopherols and total phenolics in 10 different nut types. Food Chem. 2006;98:381–7.
14. Burns J, Yokota T, Ashihara H, Lean ME, Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem. 2002;50:3337–40.[CrossRef][Medline]
15. Tokusoglu O, Unal MK, Yemis F. Determination of the phytoalexin resveratrol (3,5,4'-trihydroxystilbene) in peanuts and pistachios by high-performance liquid chromatographic diode array (HPLC-DAD) and gas chromatography-mass spectrometry (GC-MS). J Agric Food Chem. 2005;53:5003–9.[CrossRef][Medline]
16. Gu L, Kelm MA, Hammerstone JF, Beecher G, Holden J, Haytowitz D, Prior RL. Screening of foods containing proanthocyanidins and their structural characterization using LC-MS/MS and thiolytic degradation. J Agric Food Chem. 2003;51:7513–21.[CrossRef][Medline]
17. Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, Prior RL. Lipophilic and hydrophilic antioxidant capacities of common foods in the United States. J Agric Food Chem. 2004;52:4026–37.[CrossRef][Medline]
18. Chen CY, Milbury PE, Lapsley K, Blumberg JB. Flavonoids from almond skins are bioavailable and act synergistically with vitamins C and E to enhance hamster and human LDL resistance to oxidation. J Nutr. 2005;135:1366–73.
19. Jiang R, Jacobs DR Jr, Mayer-Davis E, Szklo M, Herrington D, Jenny NS, Kronmal R, Barr RG. Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2006;163:222–31.
20. Cortes B, Nunez I, Cofan M, Gilabert R, Perez-Heras A, Casals E, Deulofeu R, Ros E. Acute effects of high-fat meals enriched with walnuts or olive oil on postprandial endothelial function. J Am Coll Cardiol. 2006;48:1666–71.
21. Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, de Souza R, Emam A, Parker TL, Vidgen E, et al. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr. 2005;81:380–7.
22. Jenkins DJA, Hu FB, Tapsell LC, Josse AR, Kendall CWC. Possible benefit of nuts in type 2 diabetes. J Nutr. 2008;138:1752S–6S.
23. Mattes RD, Kris-Etherton PM, Foster GD. Impact of peanuts and tree nuts on body weight and healthy weight loss in adults. J Nutr. 2008;138:1741S–5S.
24. Seeram NP, Zhang Y, Henning SM, Lee R, Niu Y, Lin G, Heber D. Pistachio skin phenolics are destroyed by bleaching resulting in reduced antioxidative capacities. J Agric Food Chem. 2006;54:7036–40.[Medline]
25. King JC, Rechkemmer G, Geiger CJ. Second international nuts and health symposium, 2007: introduction. J Nutr. 2008;138:1734S–5S.
26. Kris-Etherton PM, Hu F, Ros E, Sabate J. The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr. 2008;138:1746S–51S.
27. Davis PA, Jenab M, Vanden Heuvel JP, Furlong T, Taylor S. Tree nut and peanut consumption in relation to chronic and metabolic diseases including allergy. J Nutr. 2008;138:1757S–62S.
28. Allen LH. Priority areas for research on the intake, composition and health effects of tree nuts and peanuts. J Nutr. 2008;138:1763S–5S.
This article has been cited by other articles:
![]() |
J. C. King, G. Rechkemmer, and C. J. Geiger Second International Nuts and Health Symposium, 2007: Introduction J. Nutr., September 1, 2008; 138(9): 1734S - 1735S. [Full Text] [PDF] |
||||
![]() |
R. D. Mattes, P. M. Kris-Etherton, and G. D. Foster Impact of Peanuts and Tree Nuts on Body Weight and Healthy Weight Loss in Adults J. Nutr., September 1, 2008; 138(9): 1741S - 1745S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Kris-Etherton, F. B. Hu, E. Ros, and J. Sabate The Role of Tree Nuts and Peanuts in the Prevention of Coronary Heart Disease: Multiple Potential Mechanisms J. Nutr., September 1, 2008; 138(9): 1746S - 1751S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. A. Jenkins, F. B. Hu, L. C. Tapsell, A. R. Josse, and C. W. C. Kendall Possible Benefit of Nuts in Type 2 Diabetes J. Nutr., September 1, 2008; 138(9): 1752S - 1756S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Davis, M. Jenab, J. P. Vanden Heuvel, T. Furlong, and S. Taylor Tree Nut and Peanut Consumption in Relation to Chronic and Metabolic Diseases Including Allergy J. Nutr., September 1, 2008; 138(9): 1757S - 1762S. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Allen Priority Areas for Research on the Intake, Composition, and Health Effects of Tree Nuts and Peanuts J. Nutr., September 1, 2008; 138(9): 1763S - 1765S. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||